Lineage Cell Therapeutics Stock Price on August 16, 2023
| LCTX Stock | USD 0.57 0.04 6.56% |
Below is the normalized historical share price chart for Lineage Cell Therapeutics extending back to March 05, 1992. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Lineage Cell stands at 0.57, as last reported on the 30th of November, with the highest price reaching 0.62 and the lowest price hitting 0.56 during the day.
If you're considering investing in Lineage Stock, it is important to understand the factors that can impact its price. Lineage Cell Therapeutics has Sharpe Ratio of -0.0875, which conveys that the firm had a -0.0875% return per unit of risk over the last 3 months. Lineage Cell exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lineage Cell's Standard Deviation of 5.7, risk adjusted performance of (0.06), and Mean Deviation of 3.66 to check out the risk estimate we provide.
At this time, Lineage Cell's Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 106.1 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 33.3 M in 2024. . At this time, Lineage Cell's Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.37 in 2024, whereas Price To Sales Ratio is likely to drop 19.99 in 2024. Lineage Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 6th of March 1992 | 200 Day MA 1.003 | 50 Day MA 0.8478 | Beta 1.282 |
Lineage |
Sharpe Ratio = -0.0875
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LCTX |
Estimated Market Risk
| 5.79 actual daily | 51 51% of assets are less volatile |
Expected Return
| -0.51 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Lineage Cell is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lineage Cell by adding Lineage Cell to a well-diversified portfolio.
Price Book 1.8943 | Enterprise Value Ebitda (8.84) | Price Sales 20.3776 | Shares Float 146.3 M | Wall Street Target Price 4.5 |
Related Headline
Nuvectis Pharma Headline on 16th of August 2023
Purchase by Bentsur Ron of 235 shares of Nuvectis Pharma by Bentsur Ron
Filed transaction by Nuvectis Pharma Inc director. General open market or private purchase of non-derivative or derivative security
Lineage Cell Valuation on August 16, 2023
It is possible to determine the worth of Lineage Cell on a given historical date. On August 16, 2023 Lineage was worth 1.46 at the beginning of the trading date compared to the closed value of 1.39. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Lineage Cell stock. Still, in general, we apply an absolute valuation method to find Lineage Cell's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lineage Cell where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Lineage Cell's related companies.
| Open | High | Low | Close | Volume | |
| 1.39 | 1.48 | 1.39 | 1.46 | 283,118 | |
08/16/2023 | 1.46 | 1.49 | 1.38 | 1.39 | 1,250,199 |
| 1.36 | 1.39 | 1.34 | 1.38 | 470,507 |
| Backtest Lineage Cell | | | Lineage Cell History | | | Lineage Cell Valuation | Previous | Next |
Lineage Cell Trading Date Momentum on August 16, 2023
| On August 17 2023 Lineage Cell Therapeutics was traded for 1.38 at the closing time. The top price for the day was 1.39 and the lowest listed price was 1.34 . The trading volume for the day was 470.5 K. The trading history from August 17, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.72% . The trading delta at closing time against the current closing price is 0.72% . |
Lineage Cell Therapeutics Fundamentals Correlations and Trends
By evaluating Lineage Cell's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Lineage Cell's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Lineage financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Lineage Cell Stock history
Lineage Cell investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lineage is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lineage Cell Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lineage Cell stock prices may prove useful in developing a viable investing in Lineage Cell
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 172.7 M | 181.3 M | |
| Net Loss | -30.2 M | -31.7 M |
Lineage Cell Quarterly Net Working Capital |
|
Lineage Cell Stock Technical Analysis
Lineage Cell technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Lineage Cell Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Lineage Cell Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NYSE MKT Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Lineage Cell November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Lineage Cell stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lineage Cell shares will generate the highest return on investment. By undertsting and applying Lineage Cell stock market strength indicators, traders can identify Lineage Cell Therapeutics entry and exit signals to maximize returns
Lineage Cell Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lineage Cell's price direction in advance. Along with the technical and fundamental analysis of Lineage Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lineage to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (1.49) | |||
| Treynor Ratio | 0.3007 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Lineage Stock Analysis
When running Lineage Cell's price analysis, check to measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.